Simponi Autoinject (generic name golimumab) is a medication that belongs to a class of drugs called biologic response modifiers or biologics. It is used to treat several chronic inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
Dosage:
The dosage of Simponi Autoinject depends on the condition being treated and the patient's weight. The medication is available as a pre-filled syringe containing 50 mg or 100 mg of golimumab, which is injected subcutaneously (under the skin). The recommended starting dose for most conditions is 50 mg per month, which can be increased to 100 mg per month for some patients.
Administration:
Simponi Autoinject is a self-administered medication that patients can inject at home after proper training from their healthcare provider. The medication should be stored in the refrigerator and allowed to come to room temperature before administration. The injection site should be rotated, and the injection should be given in a different spot each time. The patient should not inject the medication into an area that is tender, bruised, red, or hard.
Side Effects:
Like all medications, Simponi Autoinject can cause side effects. The most common side effects include injection site reactions such as pain, redness, itching, and swelling. Some patients may also experience upper respiratory infections, headache, and rash. Rarely, serious side effects such as infections and allergic reactions may occur. Patients should contact their healthcare provider if they experience any unusual symptoms or side effects.
Precautions:
Before starting treatment with Simponi Autoinject, patients should inform their healthcare provider of any medical conditions they have, including infections, tuberculosis, hepatitis B or C, or heart failure. Patients should also inform their healthcare provider of any medications they are taking, including prescription, over-the-counter, and herbal supplements. Simponi Autoinject may increase the risk of infections, including serious and potentially fatal infections such as tuberculosis and sepsis. Patients should avoid receiving live vaccines while taking Simponi Autoinject.
Conclusion:
Simponi Autoinject is a medication that is used to treat several chronic inflammatory conditions. It is a self-administered medication that patients can inject at home after proper training from their healthcare provider. The medication may cause side effects, including injection site reactions, upper respiratory infections, headache, and rash. Patients should inform their healthcare provider of any medical conditions and medications they are taking before starting treatment with Simponi Autoinject. Patients should also contact their healthcare provider if they experience any unusual symptoms or side effects.